Does pre-irradiation gross tumor volume predict the risk of progression after radiation therapy in pediatric patients with adamantinomatous craniopharyngioma?
Authors:
- 1 December 2024
- journal article
- research article
- Published by Journal of Neurosurgery Publishing Group (JNSPG) in Journal of neurosurgery. Pediatrics
- Vol. 34 (6) , 642-648
Abstract
OBJECTIVE: In a cohort of patients who were treated with resection and adjuvant radiotherapy (RT) for adamantinomatous craniopharyngioma (ACP), the authors aimed to determine whether gross tumor volume (GTV) at the initiation of RT was associated with the risk of progressive disease (PD) following treatment. METHODS: Pediatric and adolescent patients who received surgery and RT for ACP at a single institution from 1998 to 2021 were identified. Univariable Cox regression analyses (UVAs) were performed to assess the association between pre-RT GTV and PD after RT. Multivariable analyses (MVAs) were used to control for potential confounders. Two different endpoints were used to define PD. The first definition was based on radiographic tumor growth, with or without progression of clinical symptoms. The second definition was the requirement for an additional tumor-directed intervention following the completion of RT. RESULTS: Forty-eight patients were eligible for inclusion. The median age at diagnosis was 7.9 years (range 2.1–17.4 years). All patients were treated with surgery and RT with a median dose of 52.2 Gy (range 45–55.8 Gy) and median GTV of 9.86 cm3 (range 0.7–117.7 cm3). After a median follow-up of 66.4 months, 8 patients experienced PD based on both definitions. The 5-year event-free survival rate was 85.4% (95% CI 74.1%–98.3%). On both UVA and MVA, GTV was significantly associated with an increased likelihood of PD (UVA: HR 1.02, 95% CI 1.00–1.04, p = 0.02; MVA: HR 1.10, 95% CI 1.02–1.19, p = 0.01). However, after exclusion of a single outlier with a GTV of 117.7 cm3 prior to RT (remainder of the cohort: range 0.7–37.3 cm3), a second analysis identified no significant association between GTV and PD (UVA: HR 1.03, 95% CI 0.96–1.10, p = 0.4; MVA: HR 1.06, 95% CI 0.96–1.17, p = 0.24). CONCLUSIONS: The authors conclude that for most children and adolescents with ACP, the GTV at the initiation of RT is not associated with the risk of PD. This finding may influence surgical practice, because it suggests that aggressive tumor debulking for the purpose of improving the efficacy of RT may not be necessary. In the case of giant tumors, however, novel strategies may be needed for tumor control.Keywords
This publication has 17 references indexed in Scilit:
- Proton therapy and limited surgery for paediatric and adolescent patients with craniopharyngioma (RT2CR): a single-arm, phase 2 studyThe Lancet Oncology, 2023
- The implication of giant tumor size on surgical resection, oncological, and functional outcomes in craniopharyngiomaPituitary, 2020
- Giant craniopharyngiomas in children: short- and long-term implicationsChild's Nervous System, 2015
- Disease Control After Reduced Volume Conformal and Intensity Modulated Radiation Therapy for Childhood CraniopharyngiomaInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2013
- A systematic review of the results of surgery and radiotherapy on tumor control for pediatric craniopharyngiomaChild's Nervous System, 2012
- The superiority of conservative resection and adjuvant radiation for craniopharyngiomasJournal of Neuro-Oncology, 2012
- Surveillance of Craniopharyngioma Cyst Growth in Children Treated With Proton RadiotherapyInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2009
- Craniopharyngioma: Surgical experience of 309 cases in ChinaClinical Neurology and Neurosurgery, 2008
- Early adjuvant radiotherapy toward long-term survival and better quality of life for craniopharyngiomas—a study in single instituteChild's Nervous System, 2005
- Recurrence in pediatric craniopharyngiomas: analysis of clinical and histological featuresChild's Nervous System, 2005